Bottom line
What does DLHAX hold?
DLHAX held 108 positions as of Jun 30, 2026. Its largest holding is Ucb Sa at 5.19% of the fund, and the top 10 positions add up to 38.9%. By asset type it is 95% stocks, 3% preferred stock, 2% cash & short-term funds.
Updated Aug 26, 2026
DLHAX top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | Ucb Sa UCB UCB SA NPV |
Stocks | 5.19% | $39.0M |
| 2 | Abbvie Inc ABBV ABBVIE INC COM |
Stocks | 4.19% | $31.5M |
| 3 | Eli Lilly & Company LLY ELI LILLY & COMPANY COM |
Stocks | 4.16% | $31.2M |
| 4 | Regeneron Pharmaceuticals Inc REGN REGENERON PHARMACEUTICALS INC COM |
Stocks | 3.91% | $29.3M |
| 5 | Unitedhealth Group Inc UNH UNITEDHEALTH GROUP INC COM |
Stocks | 3.88% | $29.1M |
| 6 | Pfizer Inc PFE PFIZER INC COM |
Stocks | 3.84% | $28.8M |
| 7 | Merck & Company Inc MRK MERCK & COMPANY INC COM |
Stocks | 3.68% | $27.6M |
| 8 | Gilead Sciences Inc GILD GILEAD SCIENCES INC COM |
Stocks | 3.54% | $26.5M |
| 9 | Astrazeneca Plc AZN ASTRAZENECA PLC ORD USD0.25 |
Stocks | 3.27% | $24.5M |
| 10 | Elevance Health Inc ELV ELEVANCE HEALTH INC COM |
Stocks | 3.25% | $24.4M |
| 11 | Roche Holding Ag ROP ROCHE HOLDING AG CHF0.001 |
Preferred stock | 3.01% | $22.6M |
| 12 | Chugai Pharmaceutical Co Ltd 4519 CHUGAI PHARMACEUTICAL CO LTD NPV |
Stocks | 2.77% | $20.8M |
| 13 | Viatris Inc VTRS VIATRIS INC COM |
Stocks | 2.48% | $18.6M |
| 14 | Oruka Therapeutics Inc ORKA ORUKA THERAPEUTICS INC COM |
Stocks | 2.41% | $18.1M |
| 15 | Halozyme Therapeutics Inc HALO HALOZYME THERAPEUTICS INC COM |
Stocks | 2.30% | $17.2M |
| 16 | Amgen Inc AMGN AMGEN INC COM |
Stocks | 2.27% | $17.0M |
| 17 | Illumina Inc ILMN ILLUMINA INC COM |
Stocks | 2.11% | $15.8M |
| 18 | Alkermes Plc ALKS ALKERMES PLC COM USD0.01 |
Stocks | 1.82% | $13.6M |
| 19 | Viking Therapeutics Inc VKTX VIKING THERAPEUTICS INC COM |
Stocks | 1.72% | $12.9M |
| 20 | Vertex Pharmaceuticals Inc VRTX VERTEX PHARMACEUTICALS INC COM |
Stocks | 1.66% | $12.4M |
| 21 | Roivant Sciences Ltd ROIV ROIVANT SCIENCES LTD SHS |
Stocks | 1.60% | $12.0M |
| 22 | Neurocrine Biosciences Inc NBIX NEUROCRINE BIOSCIENCES INC COM |
Stocks | 1.57% | $11.8M |
| 23 | Arcus Biosciences Inc RCUS ARCUS BIOSCIENCES INC COM |
Stocks | 1.56% | $11.7M |
| 24 | Zimmer Biomet Holdings Inc ZBH ZIMMER BIOMET HOLDINGS INC COM |
Stocks | 1.42% | $10.7M |
| 25 | Boston Scientific Corp BSX BOSTON SCIENTIFIC CORP COM |
Stocks | 1.42% | $10.7M |
Source: SEC Form N-PORT, period ended Jun 30, 2026, filed Aug 26, 2026